| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0007 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |